Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

Abstract Background Direct-acting antivirals have been used for decompensated cirrhotic patients with hepatitis C virus (HCV) infection. However, the benefits in Chinese patients with decompensated cirrhosis are unclear. Methods Thirty patients with HCV infection and decompensated cirrhosis were adm...

Full description

Bibliographic Details
Main Authors: Fanpu Ji, Wenjun Wang, Shuangsuo Dang, Shengbang Wang, Burong Li, Dan Bai, Wenxue Zhao, Hong Deng, Changyin Tian, Zongfang Li
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Infectious Agents and Cancer
Subjects:
Hepatitis C virus
Sofosbuvir
Child-Pugh score
Decompensated cirrhosis
Renal dysfunction
Anemia
Online Access:http://link.springer.com/article/10.1186/s13027-017-0158-1

Internet

http://link.springer.com/article/10.1186/s13027-017-0158-1

Similar Items